Supplemental Fig. 1 from Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer

Authors :: Evan T. Keller
Shujie Xia
Atsushi Mizokami
Jill M. Keller
Jinlu Dai
Di Cui
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Figure 1. Genetic knockdown of Notch-1 inhibits growth and docetaxel chemoresistance of prostate cancer cells similar to PF-03084014.

Tools